Français
ItalianoBond Teva Pharmaceutical Industries 5.55% ( US88163VAC37 ) in USD
| Issuer | Teva Pharmaceutical Industries | ||||||
| Market price | 100.00 % ⇌ | ||||||
| Country |  Israel
|
||||||
| ISIN code |
 US88163VAC37 ( in USD )
|
||||||
| Interest rate | 5.55% per year ( payment 2 times a year) | ||||||
| Maturity | 01/02/2016 - Bond has expired | ||||||
|
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 500 000 000 USD | ||||||
| Cusip | 88163VAC3 | ||||||
| Standard & Poor's ( S&P ) rating | NR | ||||||
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||||||
| Detailed description |
Teva Pharmaceutical Industries is a global pharmaceutical company specializing in generic and specialty medications, with a focus on central nervous system disorders, respiratory diseases, oncology, and women's health. Teva Pharmaceutical Industries' USD 500,000,000 5.55% bond (CUSIP: 88163VAC3, ISIN: US88163VAC37), issued in Israel, matured on 01/02/2016, with a minimum trading size of 2,000, rated A3 by Moody's and NR by S&P, has been redeemed at 100%. |
||||||
| |||||||
